Medication and Pain Control: Experience of a Brazilian Palliative Care Referral Center

Detalhes bibliográficos
Autor(a) principal: Sampaio, Simone Garruth dos Santos Machado
Data de Publicação: 2019
Outros Autores: Motta, Luciana Branco da, Caldas, Célia Pereira
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/365
Resumo: Introduction: Pain is one of the most prevalent symptoms in cancer patients, especially in the last year of life, and its inadequate control is frequent. Objective: Outline the profile of drugs used for pain control in an exclusive oncology palliative care hospital unit. Method: A crosssectional study with longitudinal follow-up of all hospitalized patients between September and November 2016. Numeric Rating Scale (NRS), functionality and drugs with analgesic potential used were collected through medical chart review. Results: The 399 hospitalized patients presented 461 hospitalization episodes, of which 429 (93%) were patients with pain symptom (controlled or not). The mean age was 62 years, with an average of 8 days of hospitalization motivated by pain in 18% of the cases and in 35%, the pain symptom was not controlled. Of these, NRS was quantified as zero after 2 days in average. According to the Analgesic Ladder, 29% were in the 1st step, 11% in the second and 82% in the third. The use of common analgesic and of adjuvant was verified in more than 80% of the episodes. The mean equivalent dose of oral morphine was 117 mg/day. Discussion: Pain control observed was higher and earlier when compared to other similar works. The mean opioid dose (analgesic equipotent) was analogous to the observed in other studies. However, the use of strong opioids and adjuvants was more frequent than what was noticed in other services. This difference may justify the better pain control. Conclusion: The action of skilled team grants better symptom control.
id INCA-1_86bc68efd704ab20023af5b94942d5f8
oai_identifier_str oai:rbc.inca.gov.br:article/365
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Medication and Pain Control: Experience of a Brazilian Palliative Care Referral CenterMedicamentos y Control del Dolor: Experiencia de un Centro de Referencia en Cuidados Paliativos en BrasilMedicamentos e Controle de dor: Experiência de um Centro de Referência em Cuidados Paliativos no BrasilTratamento FarmacológicoCuidados PaliativosManejo da dorDor do CâncerDrug TherapyPalliative CarePain ManagementCancer PainTratamiento FarmacológicoCuidados PaliativosManejo del DolorDolor em CâncerIntroduction: Pain is one of the most prevalent symptoms in cancer patients, especially in the last year of life, and its inadequate control is frequent. Objective: Outline the profile of drugs used for pain control in an exclusive oncology palliative care hospital unit. Method: A crosssectional study with longitudinal follow-up of all hospitalized patients between September and November 2016. Numeric Rating Scale (NRS), functionality and drugs with analgesic potential used were collected through medical chart review. Results: The 399 hospitalized patients presented 461 hospitalization episodes, of which 429 (93%) were patients with pain symptom (controlled or not). The mean age was 62 years, with an average of 8 days of hospitalization motivated by pain in 18% of the cases and in 35%, the pain symptom was not controlled. Of these, NRS was quantified as zero after 2 days in average. According to the Analgesic Ladder, 29% were in the 1st step, 11% in the second and 82% in the third. The use of common analgesic and of adjuvant was verified in more than 80% of the episodes. The mean equivalent dose of oral morphine was 117 mg/day. Discussion: Pain control observed was higher and earlier when compared to other similar works. The mean opioid dose (analgesic equipotent) was analogous to the observed in other studies. However, the use of strong opioids and adjuvants was more frequent than what was noticed in other services. This difference may justify the better pain control. Conclusion: The action of skilled team grants better symptom control.Introducción: El dolor es uno de los síntomas más frecuentes en pacientes con cáncer, especialmente en el último año de vida, y el control inadecuado es frecuente. Objetivo: Este estudio fue delinear el perfil de los medicamentos utilizados para el control del dolor en una unidad hospitalaria de cuidados paliativos para el cáncer. Método: Se realizó un estudio transversal con seguimiento longitudinal de todos los pacientes hospitalizados entre septiembre y noviembre de 2016. La Escala Numérica Verbal (EVN), la funcionalidad y los medicamentos con potencial analgésico utilizados se recogieron mediante revisión de registros médicos. Resultados: Los 399 pacientes hospitalizados constituyeron 461 episodios de hospitalización, de los cuales 429 (93%) tuvieron dolor de síntomas (controlado o no). La edad promedio fue de 62 años, 8 días en promedio. La hospitalización fue motivada por dolor en el 18% de los casos y en 35% el síntoma de dolor no fue controlado. De estos, EVN se cuantificó como cero después de 2 días en promedio. Según la Escalera Analgésica, el 29% estaba en el primer paso, el 11% en el segundo y el 82% en el tercero. El uso de analgésicos y adyuvantes comunes se observó en más del 80% de los episodios. La dosis equivalente promedio de morfina oral fue de 117 mg/dia. Discusión: El control del dolor observado fue superior y anterior en comparación con otros trabajos similares. La dosis promedio de opioide (equipamiento analgésico) fue similar a la observada en otros estudios. Sin embargo, el uso de opioides y adyuvantes fuertes fue más frecuente que en otros servicios. Esta diferencia puede justificar el mejor control del dolor observado. Conclusión: La acción del equipo de expertos proporciona un mejor control de los síntomas.Introdução: A dor é um dos sintomas mais prevalentes em pacientes com câncer, especialmente no último ano de vida, sendo frequente o controle inadequado. Objetivo: Delinear o perfil de medicamentos utilizados para controle de dor em uma unidade hospitalar de cuidados paliativos oncológicos. Método: Estudo transversal com acompanhamento longitudinal de todos os pacientes internados entre setembro e novembro de 2016. Escala Verbal Numérica (EVN), funcionalidade e medicamentos com potencial analgésico utilizados foram coletados por revisão de prontuário. Resultados: Os 399 pacientes internados compuseram 461 episódios de internação, sendo 429 (93%) com o sintoma dor (controlada ou não). A idade média foi 62 anos, oito dias em média de internação, motivada por dor em 18% dos casos; e, em 35%, o sintoma dor não estava controlado. Destes, a EVN foi quantificada como zero após dois dias em média. Segundo a escada analgésica, 29% estavam no primeiro degrau, 11% no segundo e 82% no terceiro. O uso do analgésico comum e de adjuvante foi verificado em mais de 80% dos episódios. A dose média equivalente de morfina oral foi 117 mg/dia. Discussão: O controle de dor observado foi superior e mais precoce se comparado com outros trabalhos semelhantes. A dose média de opioide (equipotência analgésica) foi semelhante a observada em outros estudos. Entretanto, o uso de opioide forte e de adjuvantes foi mais frequente do que o notado em outros serviços. Essa diferença pode justificar o melhor controle álgico. Conclusão: A ação da equipe especializada proporciona melhor controle de sintomas.INCA2019-10-24info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/36510.32635/2176-9745.RBC.2019v65n2.365Revista Brasileira de Cancerologia; Vol. 65 No. 2 (2019): Apr./May/June; e-13365Revista Brasileira de Cancerologia; Vol. 65 Núm. 2 (2019): abr./mayo/jun.; e-13365Revista Brasileira de Cancerologia; v. 65 n. 2 (2019): abr./maio/jun.; e-133652176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporenghttps://rbc.inca.gov.br/index.php/revista/article/view/365/479https://rbc.inca.gov.br/index.php/revista/article/view/365/550Copyright (c) 2019 Revista Brasileira de Cancerologiainfo:eu-repo/semantics/openAccessSampaio, Simone Garruth dos Santos MachadoMotta, Luciana Branco daCaldas, Célia Pereira2021-11-29T20:03:42Zoai:rbc.inca.gov.br:article/365Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2021-11-29T20:03:42Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Medication and Pain Control: Experience of a Brazilian Palliative Care Referral Center
Medicamentos y Control del Dolor: Experiencia de un Centro de Referencia en Cuidados Paliativos en Brasil
Medicamentos e Controle de dor: Experiência de um Centro de Referência em Cuidados Paliativos no Brasil
title Medication and Pain Control: Experience of a Brazilian Palliative Care Referral Center
spellingShingle Medication and Pain Control: Experience of a Brazilian Palliative Care Referral Center
Sampaio, Simone Garruth dos Santos Machado
Tratamento Farmacológico
Cuidados Paliativos
Manejo da dor
Dor do Câncer
Drug Therapy
Palliative Care
Pain Management
Cancer Pain
Tratamiento Farmacológico
Cuidados Paliativos
Manejo del Dolor
Dolor em Câncer
title_short Medication and Pain Control: Experience of a Brazilian Palliative Care Referral Center
title_full Medication and Pain Control: Experience of a Brazilian Palliative Care Referral Center
title_fullStr Medication and Pain Control: Experience of a Brazilian Palliative Care Referral Center
title_full_unstemmed Medication and Pain Control: Experience of a Brazilian Palliative Care Referral Center
title_sort Medication and Pain Control: Experience of a Brazilian Palliative Care Referral Center
author Sampaio, Simone Garruth dos Santos Machado
author_facet Sampaio, Simone Garruth dos Santos Machado
Motta, Luciana Branco da
Caldas, Célia Pereira
author_role author
author2 Motta, Luciana Branco da
Caldas, Célia Pereira
author2_role author
author
dc.contributor.author.fl_str_mv Sampaio, Simone Garruth dos Santos Machado
Motta, Luciana Branco da
Caldas, Célia Pereira
dc.subject.por.fl_str_mv Tratamento Farmacológico
Cuidados Paliativos
Manejo da dor
Dor do Câncer
Drug Therapy
Palliative Care
Pain Management
Cancer Pain
Tratamiento Farmacológico
Cuidados Paliativos
Manejo del Dolor
Dolor em Câncer
topic Tratamento Farmacológico
Cuidados Paliativos
Manejo da dor
Dor do Câncer
Drug Therapy
Palliative Care
Pain Management
Cancer Pain
Tratamiento Farmacológico
Cuidados Paliativos
Manejo del Dolor
Dolor em Câncer
description Introduction: Pain is one of the most prevalent symptoms in cancer patients, especially in the last year of life, and its inadequate control is frequent. Objective: Outline the profile of drugs used for pain control in an exclusive oncology palliative care hospital unit. Method: A crosssectional study with longitudinal follow-up of all hospitalized patients between September and November 2016. Numeric Rating Scale (NRS), functionality and drugs with analgesic potential used were collected through medical chart review. Results: The 399 hospitalized patients presented 461 hospitalization episodes, of which 429 (93%) were patients with pain symptom (controlled or not). The mean age was 62 years, with an average of 8 days of hospitalization motivated by pain in 18% of the cases and in 35%, the pain symptom was not controlled. Of these, NRS was quantified as zero after 2 days in average. According to the Analgesic Ladder, 29% were in the 1st step, 11% in the second and 82% in the third. The use of common analgesic and of adjuvant was verified in more than 80% of the episodes. The mean equivalent dose of oral morphine was 117 mg/day. Discussion: Pain control observed was higher and earlier when compared to other similar works. The mean opioid dose (analgesic equipotent) was analogous to the observed in other studies. However, the use of strong opioids and adjuvants was more frequent than what was noticed in other services. This difference may justify the better pain control. Conclusion: The action of skilled team grants better symptom control.
publishDate 2019
dc.date.none.fl_str_mv 2019-10-24
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigos, Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/365
10.32635/2176-9745.RBC.2019v65n2.365
url https://rbc.inca.gov.br/index.php/revista/article/view/365
identifier_str_mv 10.32635/2176-9745.RBC.2019v65n2.365
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/365/479
https://rbc.inca.gov.br/index.php/revista/article/view/365/550
dc.rights.driver.fl_str_mv Copyright (c) 2019 Revista Brasileira de Cancerologia
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Revista Brasileira de Cancerologia
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 65 No. 2 (2019): Apr./May/June; e-13365
Revista Brasileira de Cancerologia; Vol. 65 Núm. 2 (2019): abr./mayo/jun.; e-13365
Revista Brasileira de Cancerologia; v. 65 n. 2 (2019): abr./maio/jun.; e-13365
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042243628957696